SEC 13F Intelligence

Commodore Capital LP / CRVS

Commodore Capital LP’s Corvus Pharmaceuticals Inc Position

Does Commodore Capital LP own Corvus Pharmaceuticals Inc (CRVS)? Yes2.26M shares worth $33M (+1.91% of its 13F portfolio) as of Q1 2026.

Position Value
$33M
Q1 2026
Shares
2.26M
% of Portfolio
+1.91%
Quarters Held
1
currently held

Position History CRVS

Reported value by quarter
Q1 ’26: $33MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.26M$33M+1.91%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Commodore Capital LP’s full portfolio or all institutional holders of CRVS.